Alan Bullimore

Alan Bullimore has extensive experience in the biopharmaceutical industry, currently serving as the Head of Business Innovation at Allergy Therapeutics since May 2015, after holding roles as Head of Communication & Market Development and Strategic Medical Marketing Manager. Prior experience includes working as a Scientific Specialist at PAREXEL from July 2013 to May 2015 and as a Scientific Project Leader at Allergy Therapeutics from August 2006 to June 2013. Academic qualifications include a PLD from IESE Business School (2017-2018) and a BSc in Biochemistry and Molecular Biology from Nottingham Trent University (2002-2006).